Stoke Therapeutics, Inc. STOK Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Stoke Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s operating margin?
- Stoke Therapeutics, Inc. (STOK) reported operating margin of -577.5% in Q1 2026.
- How has Stoke Therapeutics, Inc.'s operating margin changed year-over-year?
- Stoke Therapeutics, Inc.'s operating margin decreased by 2982.7% year-over-year, from 20% to -577.5%.
- What is the long-term trend for Stoke Therapeutics, Inc.'s operating margin?
- Over 3 years (2022 to 2025), Stoke Therapeutics, Inc.'s operating margin has grown at a -76.3% compound annual growth rate (CAGR), from -841.3% to -11.2%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.